Sarzi-Puttini, Piercarlo.
Anti-cytokine therapy in rheumatoid arthritis [electronic resource] / Piercarlo Sarzi-Puttini, Fabiola Atzeni. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (76 min.) : color, sound). - Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Characteristics of rheumatoid arthritis (RA) -- Epidemiology -- Disease pathology -- Synovitis -- Cytokine network -- Tumor necrosis factor (TNF)-alpha -- The role of TNF-alpha in rheumatoid arthritis -- Disease-modifying antirheumatic drugs (DMARD) -- TNF antagonists -- Monoclonal antibodies -- Adverse events and TNF antagonists -- Chemokines -- B cell targeting -- T cell targeting -- Costimulation -- The pipeline of new antirheumatic drugs for RA promises to bring new therapeutic possibilities for the future.
Access restricted to subscribers.
Mode of access: World Wide Web.
1514 Henry Stewart Talks
Arthritis, Rheumatoid--drug therapy.
Autoimmune Diseases.
Autoimmunity.
Research.
Anti-cytokine therapy in rheumatoid arthritis [electronic resource] / Piercarlo Sarzi-Puttini, Fabiola Atzeni. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (76 min.) : color, sound). - Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Characteristics of rheumatoid arthritis (RA) -- Epidemiology -- Disease pathology -- Synovitis -- Cytokine network -- Tumor necrosis factor (TNF)-alpha -- The role of TNF-alpha in rheumatoid arthritis -- Disease-modifying antirheumatic drugs (DMARD) -- TNF antagonists -- Monoclonal antibodies -- Adverse events and TNF antagonists -- Chemokines -- B cell targeting -- T cell targeting -- Costimulation -- The pipeline of new antirheumatic drugs for RA promises to bring new therapeutic possibilities for the future.
Access restricted to subscribers.
Mode of access: World Wide Web.
1514 Henry Stewart Talks
Arthritis, Rheumatoid--drug therapy.
Autoimmune Diseases.
Autoimmunity.
Research.